Evidence map›Paper›PMID 35255857›Full record

ArticleBMC pregnancy and childbirth2022

The optimal period for oocyte retrieval after the administration of recombinant human chorionic gonadotropin in in vitro fertilization.

Mhd Jawad Al Rahwanji, Homam Abouras, Mhd Said Shammout, Ray Altalla, Reem Al Sakaan, Nawras Alhalabi, Marwan Alhalabi

Abstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mhd Jawad Al RahwanjiDepartment of Artificial Intelligence, Faculty of Information Technology Engineering, Damascus University, Damascus, Syria. jawad.rah1g@gmail.com.ORCID http://orcid.org/0000-0001-8181-752X
Homam AbourasFaculty of Medicine, Damascus University, Damascus, Syria.ORCID http://orcid.org/0000-0002-4926-6577
Mhd Said ShammoutFaculty of Medicine, Damascus University, Damascus, Syria.ORCID http://orcid.org/0000-0002-4889-5654
Ray AltallaFaculty of Medicine, Damascus University, Damascus, Syria.ORCID http://orcid.org/0000-0001-6198-3360
Reem Al SakaanFaculty of Medicine, Damascus University, Damascus, Syria.ORCID http://orcid.org/0000-0003-1523-1373
Nawras AlhalabiFaculty of Medicine, Damascus University, Damascus, Syria.ORCID http://orcid.org/0000-0002-0119-1393
Marwan AlhalabiDivision of Reproductive Medicine, Embryology and Genetics, Faculty of Medicine, Damascus University, Damascus, Syria.ORCID http://orcid.org/0000-0003-0914-6367

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur objective was to investigate the existence of an optimal period for oocyte retrieval in regards to the clinical pregnancy occurrence after the administration of recombinant human chorionic gonadotropin (rhCG) (Ovitrelle®).

methodsWe studied the digital records of 3362 middle eastern couples who underwent in vitro fertilization (IVF) treatment between 2019 and 2021.

resultsThrough statistical testing, we found that there is a significant positive correlation between the oocyte retrieval period and the clinical pregnancy occurrence up to the 37th hour, where retrieval at the 37th hour was found to provide the most optimal outcome, especially in the case of gonadotropin-releasing hormone agonist (GnRHa) long protocol.

conclusionsThis cohort study recommends retrieval at hour 37 after ovulation triggering under the described conditions.

Indexed as

Oocyte RetrievalPregnancy RateAdultAnalysis of VarianceChorionic GonadotropinCohort StudiesFemaleFertilization in VitroHumansMiddle EastOvulation InductionPregnancyRecombinant ProteinsReproductive Control AgentsTime FactorsChorionic GonadotropinRecombinant ProteinsReproductive Control AgentsIVFIVF outcomeLong GnRH agonist protocolOocyte retrievalrhCG

Identifiers

PMID35255857
PMCPMC8902772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.